JD Health International Inc. (6618.HK) HKSE
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
JD Health International Inc.
Sector
Healthcare
Industry
Medical - Care Facilities
Employees
3564
First IPO Date
December 08, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Cao Dong | Chief Executive Officer & Director | 989,686 | 1977 |
| Deng Hui | Chief Financial Officer | 0 | 1987 |
| Ming King Chiu FCIS | Company Secretary | 0 | 1977 |
Description
JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.